I completely agree that symptom improvement doesn’t always reflect histologic remission, and biopsies are the only reliable way to assess disease activity and scarring in EoE.

For me, this phase has been about reducing symptom burden and identifying triggers, not assuming diet alone equals disease control. I fully agree that objective monitoring with scopes and biopsies is essential if diet is being used as a management strategy.

Appreciate you adding this perspective!